Aging
Navigate
Submit an Article
Research Paper|Volume 9, Issue 10|pp. 2098–2116
A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis
Back to articleFigure 1(1 of 14)
100%
Figure 1
Figure 1.Experimental strategy for understanding MYC/RAS co-operativity in human breast CSCs. More specifically, we examined how MYC/RAS co-operation affects cellular metabolism and CSC propagation, allowing for the identification of a common metabolic therapy.
Figure 1 — A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis | Aging